NZ sharemarket starts week down 0.5%

NZ sharemarket starts week down 0.5%
(Image: Getty)
Graham Skellern
Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.After a sell-down on Wall Street at the weekend, the S&P/NZX 50 Index traded weakly till a late turnaround and closed at 12,827.33, down 68.65 points or 0.53%. Volumes were light, with 30.08 million shares worth $71.1 million changing hands – nearly half of them being Pacific Edge on trade of 13.12 million shares w...

More Markets

FPH, Fletcher drive NZ stocks lower
Markets Market Close

FPH, Fletcher drive NZ stocks lower

Dips for Fisher and Paykel Healthcare and Fletcher Building drive market down.

Jamie Gray 16 May 2025
Two executives depart Bremworth
Primary Sector

Two executives depart Bremworth

The two resignations follow chief executive Greg Smith's departure. 

Riley Kennedy 16 May 2025
Forsyth Barr sees future upside in Briscoe initiatives
Retail

Forsyth Barr sees future upside in Briscoe initiatives

Management gave details on the company's roadmap for growth at the AGM on Thursday.

Gregor Thompson 16 May 2025